Ross Muken
Stock Analyst at Evercore ISI Group
(1.87)
# 3,159
Out of 5,162 analysts
49
Total ratings
53.57%
Success rate
-1.25%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Ross Muken
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| CRL Charles River Laboratories International | Maintains: Outperform | $260 → $200 | $155.46 | +28.65% | 11 | Feb 19, 2026 | |
| HSIC Henry Schein | Maintains: In-Line | $78 → $70 | $75.57 | -7.37% | 10 | Aug 6, 2025 | |
| ICLR ICON Public Limited Company | Maintains: Outperform | $170 → $240 | $98.33 | +144.08% | 9 | Jul 25, 2025 | |
| A Agilent Technologies | Maintains: In-Line | $126 → $130 | $111.51 | +16.58% | 11 | Jul 2, 2024 | |
| QGEN Qiagen | Downgrades: In-Line | n/a | $40.60 | - | 2 | Jul 16, 2019 | |
| CAH Cardinal Health | Initiates: In-Line | $67 | $217.08 | -69.14% | 2 | Jan 5, 2018 | |
| ILMN Illumina | Initiates: Outperform | $250 | $118.94 | +110.19% | 2 | Jan 4, 2018 | |
| TMO Thermo Fisher Scientific | Initiates: Outperform | $220 | $464.37 | -52.62% | 1 | Jan 4, 2018 | |
| MBLY Mobileye Global | Downgrades: In-Line | n/a | $7.57 | - | 1 | Mar 13, 2017 |
Charles River Laboratories International
Feb 19, 2026
Maintains: Outperform
Price Target: $260 → $200
Current: $155.46
Upside: +28.65%
Henry Schein
Aug 6, 2025
Maintains: In-Line
Price Target: $78 → $70
Current: $75.57
Upside: -7.37%
ICON Public Limited Company
Jul 25, 2025
Maintains: Outperform
Price Target: $170 → $240
Current: $98.33
Upside: +144.08%
Agilent Technologies
Jul 2, 2024
Maintains: In-Line
Price Target: $126 → $130
Current: $111.51
Upside: +16.58%
Qiagen
Jul 16, 2019
Downgrades: In-Line
Price Target: n/a
Current: $40.60
Upside: -
Cardinal Health
Jan 5, 2018
Initiates: In-Line
Price Target: $67
Current: $217.08
Upside: -69.14%
Illumina
Jan 4, 2018
Initiates: Outperform
Price Target: $250
Current: $118.94
Upside: +110.19%
Thermo Fisher Scientific
Jan 4, 2018
Initiates: Outperform
Price Target: $220
Current: $464.37
Upside: -52.62%
Mobileye Global
Mar 13, 2017
Downgrades: In-Line
Price Target: n/a
Current: $7.57
Upside: -